Navigation auf uzh.ch

URPP Evolution in Action: From Genomes to Ecosystems

Tom Loosli

Tom Loosli

  • PhD students representative
  • Institute of Medical Virology
  • Department of Infectious Diseases and Hospital Epidemiology

Supervisor:

Roger Kouyos

PhD project:

Is Dolutegravir-Based Combination Antiretroviral Therapy Evolution Proof in Sub-Saharan Africa

 

Publication:

Loosli T, Hossmann S, Ingle SM, Okhai H, Kusejko K, Mouton J, Bellecave P, van Sighem A, Stecher A, d’Arminio Monforte A, Gill MJ, Sabin CA, Maartens G, Günthard HF, Sterne JAC, Lessells R, Egger M, Kouyos R (2023).

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis (https://doi.org/10.1016/S2352-3018(23)00228-X)

The Lancet HIV, October 2023